IBRN – iShares Trust - iShares Neuroscience and Healthcare ETF
iShares Trust - iShares Neuroscience and Healthcare ETF (IBRN) is a Health ETF, issued by iShares, $5M in assets, 0.47% expense ratio.
Returns as of Oct 26, 2026: 1 week +2.6%, 1 year +31.9%.
Tracks an index of neuroscience and healthcare companies. May use futures, options, and swaps. Non-diversified.
Top holdings
- PRAX – Praxis Precision Medicines Inc, 5.2%
- AXSM – Axsome Therapeutics Inc, 5.0%
- ALKS – Alkermes Plc, 4.3%
- SRRK – Scholar Rock Holding Corp, 4.0%
- ACAD – ACADIA Pharmaceuticals Inc, 3.8%
- PTCT – PTC Therapeutics Inc, 3.8%
- XENE – Xenon Pharmaceuticals Inc, 3.7%
- BIIB – Biogen Inc, 3.7%
- SUPN – Supernus Pharmaceuticals Inc, 3.6%
- NBIX – Neurocrine Biosciences Inc, 3.5%
- CPRX – Catalyst Pharmaceuticals Inc, 3.4%
- DNLI – Denali Therapeutics Inc, 3.0%
- EWTX – Edgewise Therapeutics Inc, 2.9%
- SRPT – Sarepta Therapeutics Inc, 2.8%
- AVDL – Avadel Pharmaceuticals PLC, 2.7%
- HLUN-B – H Lundbeck A/S, 2.4%
- DYN – Dyne Therapeutics Inc, 2.3%
- DNTH – Dianthus Therapeutics Inc., 2.2%
- AXGN – Axogen Inc, 1.9%
- BHVN – Biohaven Pharmaceutical Holding Co Ltd, 1.8%
- BIOA-B – BioArctic AB (publ), 1.7%
- DYVOX – Dynavox Group, 1.4%
- TSHA – Taysha Gene Therapies Inc, 1.4%
- CAPR – Capricor Therapeutics Inc, 1.3%
- IART – Integra LifeSciences Holdings, 1.1%